Date of dispatch of this notice: 13/07/2020
Expire date: 14/08/2020
External Reference: 2020-234457
TED Reference: 2020/S 136-334989
Contract notice
Information
Published
Contract notice
[NoticeContract]
[Directive201424]
[Section1]: [Ca]
I.1)
[NameAddressContact]
Education Procurement Service (EPS)
IE 6609370 G
University of Limerick
Castletroy
Co.Limerick
IE
[Contactpoint]:
Linda Maher
[AddressPhone]:
+353 61233715
[AddressEmail]:
linda.maher@ul.ie
[Internets]:
[UrlGeneral]:
http://www.educationprocurementservice.ie
[UrlBuyerprofile]:
https://irl.eu-supply.com/ctm/Company/CompanyInformation/Index/87073
I.2)
[JointProcurement]
[JointProcurementCentral]
I.3)
[InfoTendering]
[AddressObtainDocs]:
http://irl.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=170425&B=ETENDERS_SIMPLE[AddressFurtherinfo]
[AsContactsAbove]:
[AddressSendTendersRequest]
[AddressSendTenders]:
http://irl.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=170425&B=ETENDERS_SIMPLE
[AddressSendTendersRequest]
[AddressToAbove]
I.4)
[CaType]
[MaintypePublicbody]
I.5)
[Mainactivity]
[MainactivEducation]
[Section2]: [Object]
II.1)
[QuantityScopeContract]
II.1.1)
[TitleContract]
LEE882C - NUI Galway - Preclinical Evaluation of Hydrobloc
II.1.2)
[CpvMain]
73110000
-
II.1.3)
[TypeContract]
[Services]
II.1.4)
[DescrShort]
NUI Galway wishes to source and appoint a suitably qualified and experienced Contract Research Organisation (CRO) to support the research and development requirements for their Preclinical Evaluation of Hydrobloc.
The goal of the project is to develop a novel stabilised gel for the treatment of chronic pain. Specifically, this 12-month project aims to develop the Hydrobloc technology and complete all necessary safety and efficacy testing in order for this novel medical device to be ready for first in human trials.
This tender is split into three lots as follows;
• Lot 1: Pre-Clinical Efficacy Studies in a model of Osteoarthritis.
• Lot 2: Pre-Clinical Efficacy Study in a model of Neuropathic Pain.
• Lot 3: Pre-Clinical Biocompatibility and Safety Studies (in compliance with ISO 10993).
The goal of the project is to develop a novel stabilised gel for the treatment of chronic pain. Specifically, this 12-month project aims to develop the Hydrobloc technology and complete all necessary safety and efficacy testing in order for this novel medical device to be ready for first in human trials.
This tender is split into three lots as follows;
• Lot 1: Pre-Clinical Efficacy Studies in a model of Osteoarthritis.
• Lot 2: Pre-Clinical Efficacy Study in a model of Neuropathic Pain.
• Lot 3: Pre-Clinical Biocompatibility and Safety Studies (in compliance with ISO 10993).
II.1.5)
[ValueMagnitudeEstimatedTotal]
[ValueExclVat]: 28000.00
EUR
II.1.6)
[LotsInfo]
[DivisionLots]:
[Yes]
[LotsSubmittedFor]
[LotsAll]
II.2)
[Description]
II.2.1)
[TitleContract]
Lot 1 - Pre-Clinical Efficacy Studies
[LotNumber]:
1
II.2.2)
[CpvAdditional]
71620000
-
71900000
-
73000000
-
73111000
-
73210000
-
73300000
-
II.2.3)
[PlacePerformance]
[MainsiteplaceWorksDelivery]:
NUI Galway
II.2.4)
[DescrProcurement]
Pre-Clinical Efficacy Studies in a model of Osteoarthritis.
II.2.5)
[AwardCriteria]
[AwardCriteriaDescriptive]
II.2.7)
[DurationContractFrameworkDps]
[DurationMonths]:
12
[RenewalsSubject]:
[No]
II.2.10)
[VariantsInfo]
[VariantsAccepted]:
[No]
II.2.11)
[OptionsInfo]
[Options]:
[No]
II.2.13)
[EuProgrInfo]
[EuProgrRelated]:
[No]
II.2)
[Description]
II.2.1)
[TitleContract]
Lot 2 - Pre-Clinical Efficacy Study
[LotNumber]:
2
II.2.2)
[CpvAdditional]
71620000
-
71900000
-
73000000
-
73111000
-
73210000
-
73300000
-
II.2.3)
[PlacePerformance]
[MainsiteplaceWorksDelivery]:
NUI Galway
II.2.4)
[DescrProcurement]
Lot 2: Pre-Clinical Efficacy Study in a model of Neuropathic Pain.
II.2.5)
[AwardCriteria]
[AwardCriteriaDescriptive]
II.2.7)
[DurationContractFrameworkDps]
[DurationMonths]:
12
[RenewalsSubject]:
[No]
II.2.10)
[VariantsInfo]
[VariantsAccepted]:
[No]
II.2.11)
[OptionsInfo]
[Options]:
[No]
II.2.13)
[EuProgrInfo]
[EuProgrRelated]:
[No]
II.2)
[Description]
II.2.1)
[TitleContract]
Lot 3 - Pre-Clinical Biocompatibility and Safety Studies
[LotNumber]:
3
II.2.2)
[CpvAdditional]
71620000
-
71900000
-
73000000
-
73111000
-
73210000
-
73300000
-
II.2.3)
[PlacePerformance]
[MainsiteplaceWorksDelivery]:
NUI Galway
II.2.4)
[DescrProcurement]
Lot 3: Pre-Clinical Biocompatibility and Safety Studies (in compliance with ISO 10993)
II.2.5)
[AwardCriteria]
[AwardCriteriaDescriptive]
II.2.7)
[DurationContractFrameworkDps]
[DurationMonths]:
12
[RenewalsSubject]:
[No]
II.2.10)
[VariantsInfo]
[VariantsAccepted]:
[No]
II.2.11)
[OptionsInfo]
[Options]:
[No]
II.2.13)
[EuProgrInfo]
[EuProgrRelated]:
[No]
[Section3]: [InfoLegal]
III.1)
[ConditionsParticip]
III.1.1)
[SituationPersonalIncl]
[InfoEvaluatingRequir]:
Please see RFT document for further details.
III.1.2)
[EconomicFinancialStanding]
[InfoEvaluatingWethRequir]:
Please see RFT document for further details.
[MinStandardsRequired]:
Please see RFT document for further details.
III.1.3)
[TechnicalCapacity]
[InfoEvaluatingWethRequir]:
Please see RFT document for further details.
[MinStandardsRequired]:
Please see RFT document for further details.
III.2)
[ConditionsContract]
III.2.2)
[OtherConditions]
Please see RFT document for further details.
[Section4]: [Procedure]
IV.1)
[Description]
IV.1.1)
[TypeProcedure]
[ProctypeOpen]
IV.1.8)
[GpaInfo]
[GpaCovered]
: [Yes]
IV.2)
[InfoAdmin]
IV.2.2)
[LimitReceiptTendersReqPart]
[Date]:
14/08/2020
[Time]:
14:00
IV.2.4)
[LanguagesAllowed]
[Language_EN]
IV.2.6)
[MinTimeMaintain]
[DurationMonths]
: 12
([FromStatedDate])
IV.2.7)
[OpeningConditions]
[Date]:
14/08/2020
[Time]:
14:00
[Section6]: [InfoComplement]
VI.1)
[RecurrenceInfo]
[RecurrentProcurement]:
[No]
VI.4)
[AppealsProcedure]
VI.4.1)
[AppealsBody]
Office of the High Court
Four Courts Ground Floor, Inns Quay
Dublin
7
IE
[AddressPhone]:
+353 18886000
[AddressEmail]:
HighCourtCentralOffice@courts.ie